Manufacturing of recombinant therapeutic proteins in microbial systems
- PMID:16892246
- DOI: 10.1002/biot.200500051
Manufacturing of recombinant therapeutic proteins in microbial systems
Abstract
Recombinant therapeutic proteins have gained enormous importance for clinical applications. The first recombinant products have been produced in E. coli more than 20 years ago. Although with the advent of antibody-based therapeutics mammalian expression systems have experienced a major boost, microbial expression systems continue to be widely used in industry. Their intrinsic advantages, such as rapid growth, high yields and ease of manipulation, make them the premier choice for expression of non-glycosylated peptides and proteins. Innovative product classes such as antibody fragments or alternative binding molecules will further expand the use of microbial systems. Even more, novel, engineered production hosts and integrated technology platforms hold enormous potential for future applications. This review summarizes current applications and trends for development, production and analytical characterization of recombinant therapeutic proteins in microbial systems.
Comment in
- The art of bioprocessing.Jungbauer A.Jungbauer A.Biotechnol J. 2006 Feb;1(2):111. doi: 10.1002/biot.200690030.Biotechnol J. 2006.PMID:16892235No abstract available.
Similar articles
- Antibodies and genetically engineered related molecules: production and purification.Roque AC, Lowe CR, Taipa MA.Roque AC, et al.Biotechnol Prog. 2004 May-Jun;20(3):639-54. doi: 10.1021/bp030070k.Biotechnol Prog. 2004.PMID:15176864Review.
- Proteomic profiling of Escherichia coli proteins under high cell density fed-batch cultivation with overexpression of phosphogluconolactonase.Wang Y, Wu SL, Hancock WS, Trala R, Kessler M, Taylor AH, Patel PS, Aon JC.Wang Y, et al.Biotechnol Prog. 2005 Sep-Oct;21(5):1401-11. doi: 10.1021/bp050048m.Biotechnol Prog. 2005.PMID:16209543
- Engineering cell physiology to enhance recombinant protein production in Escherichia coli.Chou CP.Chou CP.Appl Microbiol Biotechnol. 2007 Sep;76(3):521-32. doi: 10.1007/s00253-007-1039-0. Epub 2007 Jun 15.Appl Microbiol Biotechnol. 2007.PMID:17571257Review.
- Plant cell cultures for the production of recombinant proteins.Hellwig S, Drossard J, Twyman RM, Fischer R.Hellwig S, et al.Nat Biotechnol. 2004 Nov;22(11):1415-22. doi: 10.1038/nbt1027.Nat Biotechnol. 2004.PMID:15529167Review.
- The rapid discovery of engineered antibodies.Wang M, He M.Wang M, et al.IDrugs. 2007 Aug;10(8):562-5.IDrugs. 2007.PMID:17665332Review.
Cited by
- Techniques for Monitoring Protein Misfolding and Aggregation in Vitro and in Living Cells.Gregoire S, Irwin J, Kwon I.Gregoire S, et al.Korean J Chem Eng. 2012 Jun;29(6):693-702. doi: 10.1007/s11814-012-0060-x.Korean J Chem Eng. 2012.PMID:23565019Free PMC article.
- Ileal inflammation is reduced due to treatment with a metalloprotease from BmooMP-α-I snake venom in an experimental model of Toxoplasma gondii infection.Silva TL, Lopes CS, Silva MC, Ferreira FB, Barros HLS, Silva MF, Silva NM, Oliveira F, Mineo TWP, Mineo JR.Silva TL, et al.Parasitol Res. 2023 Dec 22;123(1):65. doi: 10.1007/s00436-023-08033-9.Parasitol Res. 2023.PMID:38133827
- Protein Folding Using a Vortex Fluidic Device.Britton J, Smith JN, Raston CL, Weiss GA.Britton J, et al.Methods Mol Biol. 2017;1586:211-220. doi: 10.1007/978-1-4939-6887-9_13.Methods Mol Biol. 2017.PMID:28470607Free PMC article.
- High-throughput screening and selection of yeast cell lines expressing monoclonal antibodies.Barnard GC, Kull AR, Sharkey NS, Shaikh SS, Rittenhour AM, Burnina I, Jiang Y, Li F, Lynaugh H, Mitchell T, Nett JH, Nylen A, Potgieter TI, Prinz B, Rios SE, Zha D, Sethuraman N, Stadheim TA, Bobrowicz P.Barnard GC, et al.J Ind Microbiol Biotechnol. 2010 Sep;37(9):961-71. doi: 10.1007/s10295-010-0746-1. Epub 2010 Aug 15.J Ind Microbiol Biotechnol. 2010.PMID:20711797
- Enzyme replacement therapy for Morquio A: an active recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Escherichia coli BL21.Rodríguez A, Espejo AJ, Hernández A, Velásquez OL, Lizaraso LM, Cordoba HA, Sánchez OF, Alméciga-Díaz CJ, Barrera LA.Rodríguez A, et al.J Ind Microbiol Biotechnol. 2010 Nov;37(11):1193-201. doi: 10.1007/s10295-010-0766-x. Epub 2010 Jun 27.J Ind Microbiol Biotechnol. 2010.PMID:20582614
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources